Ragupathi G - Search Results

1

A polyvalent vaccine for high-risk prostate patients: "are more antigens better?".

Slovin SF, Ragupathi G, Fernandez C, Diani M, Jefferson MP, Wilton A, Kelly WK, Morris M, Solit D, Clausen H, Livingston P, Scher HI. Slovin SF, et al. Among authors: ragupathi g. Cancer Immunol Immunother. 2007 Dec;56(12):1921-30. doi: 10.1007/s00262-007-0335-y. Epub 2007 Jul 10. Cancer Immunol Immunother. 2007. PMID: 17619878 Free PMC article. Clinical Trial.

2

Augmenting the immunogenicity of synthetic MUC1 peptide vaccines in mice.

Zhang S, Graeber LA, Helling F, Ragupathi G, Adluri S, Lloyd KO, Livingston PO. Zhang S, et al. Among authors: ragupathi g. Cancer Res. 1996 Jul 15;56(14):3315-9. Cancer Res. 1996. PMID: 8764127

3

Carbohydrate antigens as targets for active specific immunotherapy.

Ragupathi G. Ragupathi G. Cancer Immunol Immunother. 1996 Nov;43(3):152-7. doi: 10.1007/s002620050316. Cancer Immunol Immunother. 1996. PMID: 9001568 Review.

4

Tumor cell reactivity mediated by IgM antibodies in sera from melanoma patients vaccinated with GM2 ganglioside covalently linked to KLH is increased by IgG antibodies.

Livingston P, Zhang S, Adluri S, Yao TJ, Graeber L, Ragupathi G, Helling F, Fleisher M. Livingston P, et al. Among authors: ragupathi g. Cancer Immunol Immunother. 1997 Jan;43(6):324-30. doi: 10.1007/s002620050340. Cancer Immunol Immunother. 1997. PMID: 9067403 Free PMC article.

5

Carbohydrate vaccines that induce antibodies against cancer. 2. Previous experience and future plans.

Livingston PO, Ragupathi G. Livingston PO, et al. Among authors: ragupathi g. Cancer Immunol Immunother. 1997 Oct;45(1):10-9. doi: 10.1007/s002620050395. Cancer Immunol Immunother. 1997. PMID: 9353422 Free PMC article. Review.

6

Immunogenicity of synthetic conjugates of Lewis(y) oligosaccharide with proteins in mice: towards the design of anticancer vaccines.

Kudryashov V, Kim HM, Ragupathi G, Danishefsky SJ, Livingston PO, Lloyd KO. Kudryashov V, et al. Among authors: ragupathi g. Cancer Immunol Immunother. 1998 Feb;45(6):281-6. doi: 10.1007/s002620050444. Cancer Immunol Immunother. 1998. PMID: 9490197 Free PMC article.

7

A novel and efficient method for synthetic carbohydrate conjugate vaccine preparation: synthesis of sialyl Tn-KLH conjugate using a 4-(4-N-maleimidomethyl) cyclohexane-1-carboxyl hydrazide (MMCCH) linker arm.

Ragupathi G, Koganty RR, Qiu D, Lloyd KO, Livingston PO. Ragupathi G, et al. Glycoconj J. 1998 Mar;15(3):217-21. doi: 10.1023/a:1006936826730. Glycoconj J. 1998. PMID: 9579798

8

Characterization of a mouse monoclonal IgG3 antibody to the tumor-associated globo H structure produced by immunization with a synthetic glycoconjugate.

Kudryashov V, Ragupathi G, Kim IJ, Breimer ME, Danishefsky SJ, Livingston PO, Lloyd KO. Kudryashov V, et al. Among authors: ragupathi g. Glycoconj J. 1998 Mar;15(3):243-9. doi: 10.1023/a:1006992911709. Glycoconj J. 1998. PMID: 9579801

9

Antibodies against GD2 ganglioside can eradicate syngeneic cancer micrometastases.

Zhang H, Zhang S, Cheung NK, Ragupathi G, Livingston PO. Zhang H, et al. Among authors: ragupathi g. Cancer Res. 1998 Jul 1;58(13):2844-9. Cancer Res. 1998. PMID: 9661900

10

Selection of tumor antigens as targets for immune attack using immunohistochemistry: protein antigens.

Zhang S, Zhang HS, Cordon-Cardo C, Ragupathi G, Livingston PO. Zhang S, et al. Among authors: ragupathi g. Clin Cancer Res. 1998 Nov;4(11):2669-76. Clin Cancer Res. 1998. PMID: 9829729

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters